Aortica has raised $1 million in a new round of mixed financing, according to an SEC filing posted this week.
Money in the round comes from 11 unnamed investors, with the 1st sale recorded on June 13 this year.
The company is looking for an additional $3 million in the round before closing it, according to the SEC filing. Aortica has not yet stated how it plans to spend funds raised in the round.
In February, Aortica said that midterm data from a physician-sponsored investigational device exemption trial was “highly favorable.”
In the trial, researchers are examining physician-modified endovascular grafts for treating juxtarenal aortic aneurysms and assessing a new technology designed by Aortica to reduce the need for invasive open surgeries.
Midterm results were published in the Feb. issue of the Journal of Vascular Surgery.